\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ metabolic\\ abnormality\\.\ \(0\)\
\-\ resection\\,\\ if\\ complete\\,\\ is\\ usually\\ sufficient\\.\\ \\ it\\ has\\ not\\ yet\\ been\\ decided\\ if\\ this\\ patient\\ will\\ undergo\\ additional\\ tx\\.\ \(0\)\
\-\ large\\,\\ solid\\ mass\\ in\\ the\\ left\\ cerebellar\\ hemisphere\\ with\\ ill\\-defined\\ margins\\ and\\ significant\\ surrounding\\ t2\\ signal\\ abnormality\\ representing\\ vasogenic\\ edema\\.\\ \\ this\\ exerts\\ mass\\ effect\\ upon\\ and\\ displaces\\ the\\ 4th\\ ventricle\\.\\ \\ mild\\ hydrocephalus\\.\\ \\ diffuse\\,\\ heterogeneous\\ enhancement\\ following\\ iv\\ gadolinium\\ infusion\\.\\ \\ ct\\ scan\\ demonstrates\\ a\\ notably\\ low\\ attenuation\\ mass\\,\\ and\\ inferior\\ displacement\\ of\\ the\\ cerebellar\\ tonsils\\ to\\ the\\ level\\ of\\ the\\ foramen\\ magnum\\.\ \(0\)\
\-\ pilocytic\\ astrocytoma\ \(31\)\
\-\ \\<li\\>astrocytoma\\ \\(pilocytic\\ or\\ fibrillary\\)\ \(0\)\
\-\ \\<li\\>ependymoma\ \(0\)\
\-\ \\<li\\>medulloblastoma\ \(0\)\
\-\ his\\ mother\\ provides\\ a\\ history\\ of\\ increasing\\ headaches\\ over\\ past\\ month\\,\\ gait\\ disturbances\\,\\ and\\ possible\\ seizure\\ activity\\.\ \(0\)\
\-\ the\\ mass\\ arises\\ from\\ the\\ left\\ cerebellar\\ hemisphere\\ and\\ not\\ the\\ 4th\\ ventricle\\,\\ and\\ is\\ hypodense\\ on\\ ct\\.\\ \\ these\\ findings\\ make\\ medulloblastoma\\ far\\ less\\ likely\\.\\ \\ a\\ mass\\ entirely\\ outside\\ the\\ ventricle\\ makes\\ ependyoma\\ less\\ likely\\.\\ \\ while\\ pilocytic\\ astrocytomas\\ \\(pa\\)\\ are\\ usually\\ cystic\\ with\\ an\\ enhancing\\ mural\\ nodule\\,\\ this\\ case\\ represents\\ the\\ less\\ common\\ solid\\ variant\\.\\ \\ approximately\\ 85\\%\\ of\\ posterior\\ fossa\\ astrocytomas\\ in\\ childhood\\ are\\ pilocytic\\ \\-\\ the\\ remainder\\ are\\ fibrillary\\-diffuse\\.\\ \\ pilocytic\\ astrocytomas\\ are\\ who\\ grade\\ 1\\;\\ whereas\\ fibrillary\\ may\\ be\\ grade\\ 2\\-4\\.\\ enhancement\\ in\\ pa\\ is\\ almost\\ universal\\.\\ \\ enhancement\\ in\\ diffuse\\ astrocytoma\\ is\\ associated\\ with\\ vascular\\ changes\\ and\\ a\\ higher\\ tumor\\ grade\\ \\-\\ either\\ grade\\ 3\\ or\\ grade\\ 4\\.\ \(0\)\
\-\ click\\ here\\ to\\ see\\ other\\ pilocytic\\ astrocytomas\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/medpix\\.html\\?mode\\=image\\_finder\\&action\\=search\\&srchstr\\=pilocytic\\%20astrocytoma\\&srch\\_type\\=all\\#top\ \(1\)\
\-\ click\\ here\\ to\\ see\\ medulloblastoma\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/medpix\\.html\\?mode\\=image\\_finder\\&action\\=search\\&srchstr\\=medulloblastoma\\&srch\\_type\\=all\\#top\ \(1\)\
\-\ click\\ here\\ to\\ see\\ ependymoma\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/medpix\\.html\\?mode\\=image\\_finder\\&action\\=search\\&srchstr\\=ependymoma\\&srch\\_type\\=all\\#top\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pilocytic\\:\\ 0\\.3175468146616784\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.22615949736401936\ \(0\)\
\-\ fibrillary\\:\\ 0\\.19956381261322662\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.19644384310069876\ \(0\)\
\-\ grade\\:\\ 0\\.1700330349700404\ \(0\)\
\-\ click\\:\\ 0\\.16614358262995838\ \(0\)\
\-\ top\\:\\ 0\\.13846196588538137\ \(0\)\
\-\ here\\:\\ 0\\.13514088643688638\ \(0\)\
\-\ li\\:\\ 0\\.1345267527369996\ \(0\)\
\-\ ependymoma\\:\\ 0\\.11984051142517073\ \(0\)\
\-\ cerebellar\\:\\ 0\\.11610282003880792\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.10710210315310817\ \(0\)\
\-\ http\\:\\ 0\\.10488773447419505\ \(0\)\
\-\ ventricle\\:\\ 0\\.10443137027300765\ \(0\)\
\-\ the\\:\\ 0\\.10379975036479229\ \(0\)\
\-\ less\\:\\ 0\\.09651928262127371\ \(0\)\
\-\ mass\\:\\ 0\\.09032019524289832\ \(0\)\
\-\ diffuse\\:\\ 0\\.08897261854934187\ \(0\)\
\-\ hemisphere\\:\\ 0\\.08851360836624478\ \(0\)\
\-\ see\\:\\ 0\\.08825444109149132\ \(0\)\
\-\ 4th\\:\\ 0\\.08707089296064688\ \(0\)\
\-\ enhancement\\:\\ 0\\.08166025967890445\ \(0\)\
\-\ ependyoma\\:\\ 0\\.07562918829795148\ \(0\)\
\-\ 20astrocytoma\\:\\ 0\\.07562918829795148\ \(0\)\
\-\ pa\\:\\ 0\\.07258376050607895\ \(0\)\
\-\ solid\\:\\ 0\\.0725118264781562\ \(0\)\
\-\ universal\\:\\ 0\\.07226772696876356\ \(0\)\
\-\ are\\:\\ 0\\.07177968916343232\ \(0\)\
\-\ abnormality\\:\\ 0\\.06879758571857408\ \(0\)\
\-\ and\\:\\ 0\\.06840527141222807\ \(0\)\
\-\ exerts\\:\\ 0\\.06413627610257544\ \(0\)\
\-\ usually\\:\\ 0\\.05954333312325083\ \(0\)\
\-\ notably\\:\\ 0\\.05788721862746328\ \(0\)\
\-\ likely\\:\\ 0\\.05652030179264013\ \(0\)\
\-\ if\\:\\ 0\\.05495491677131942\ \(0\)\
\-\ infusion\\:\\ 0\\.05436477391551265\ \(0\)\
\-\ disturbances\\:\\ 0\\.05436477391551265\ \(0\)\
\-\ decided\\:\\ 0\\.05405189211501167\ \(0\)\
\-\ magnum\\:\\ 0\\.053459469883736135\ \(0\)\
\-\ tonsils\\:\\ 0\\.052643363907199384\ \(0\)\
\-\ sufficient\\:\\ 0\\.05214076252977526\ \(0\)\
\-\ displaces\\:\\ 0\\.05214076252977526\ \(0\)\
\-\ tx\\:\\ 0\\.05190044472614848\ \(0\)\
\-\ provides\\:\\ 0\\.05190044472614848\ \(0\)\
\-\ is\\:\\ 0\\.05180424661989345\ \(0\)\
\-\ entirely\\:\\ 0\\.051439749337099626\ \(0\)\
\-\ arises\\:\\ 0\\.050588707010021224\ \(0\)\
\-\ whereas\\:\\ 0\\.050193852208312024\ \(0\)\
\-\ this\\:\\ 0\\.04875049418040422\ \(0\)\
\-\ mural\\:\\ 0\\.04830543601732364\ \(0\)\
\-\ far\\:\\ 0\\.04815331461692784\ \(0\)\
\-\ yet\\:\\ 0\\.04785719800659894\ \(0\)\
\-\ childhood\\:\\ 0\\.04785719800659894\ \(0\)\
\-\ makes\\:\\ 0\\.04743195691412889\ \(0\)\
\-\ to\\:\\ 0\\.047290993611515314\ \(0\)\
\-\ in\\:\\ 0\\.04705822743890245\ \(0\)\
\-\ vasogenic\\:\\ 0\\.04651712917801403\ \(0\)\
\-\ hypodense\\:\\ 0\\.045920441248823544\ \(0\)\
\-\ make\\:\\ 0\\.045920441248823544\ \(0\)\
\-\ representing\\:\\ 0\\.04474176018237438\ \(0\)\
\-\ undergo\\:\\ 0\\.04416312653426046\ \(0\)\
\-\ 85\\:\\ 0\\.04362225757421626\ \(0\)\
\-\ higher\\:\\ 0\\.04295196266901331\ \(0\)\
\-\ metabolic\\:\\ 0\\.0428718617201366\ \(0\)\
\-\ almost\\:\\ 0\\.042482570312248634\ \(0\)\
\-\ represents\\:\\ 0\\.042257478194655\ \(0\)\
\-\ foramen\\:\\ 0\\.0420383363507275\ \(0\)\
\-\ variant\\:\\ 0\\.041966557688360086\ \(0\)\
\-\ remainder\\:\\ 0\\.04161670055673341\ \(0\)\
\-\ gait\\:\\ 0\\.04095838790083542\ \(0\)\
\-\ mother\\:\\ 0\\.04040753253077243\ \(0\)\
\-\ margins\\:\\ 0\\.040348525991890684\ \(0\)\
\-\ gadolinium\\:\\ 0\\.0394047889791008\ \(0\)\
\-\ seizure\\:\\ 0\\.0393524835455669\ \(0\)\
\-\ either\\:\\ 0\\.039095794814645174\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.038605096359172156\ \(0\)\
\-\ displacement\\:\\ 0\\.038557586866889856\ \(0\)\
\-\ outside\\:\\ 0\\.03796353122339058\ \(0\)\
\-\ not\\:\\ 0\\.03733901206629669\ \(0\)\
\-\ nodule\\:\\ 0\\.03732712807350373\ \(0\)\
\-\ increasing\\:\\ 0\\.0372458491507626\ \(0\)\
\-\ upon\\:\\ 0\\.037205506571325285\ \(0\)\
\-\ fossa\\:\\ 0\\.03712540562244857\ \(0\)\
\-\ of\\:\\ 0\\.037018843384047\ \(0\)\
\-\ additional\\:\\ 0\\.03666040242155179\ \(0\)\
\-\ attenuation\\:\\ 0\\.03618444397133724\ \(0\)\
\-\ ct\\:\\ 0\\.03600853347384032\ \(0\)\
\-\ headaches\\:\\ 0\\.035275459958566006\ \(0\)\
\-\ activity\\:\\ 0\\.03472050596151775\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.03422843651485346\ \(0\)\
\-\ iv\\:\\ 0\\.033790558710065755\ \(0\)\
\-\ effect\\:\\ 0\\.03317427131875541\ \(0\)\
\-\ complete\\:\\ 0\\.03314956076777906\ \(0\)\
\-\ or\\:\\ 0\\.03290364772261949\ \(0\)\
\-\ left\\:\\ 0\\.03226423218189165\ \(0\)\
\-\ inferior\\:\\ 0\\.03217309420709123\ \(0\)\
\-\ possible\\:\\ 0\\.03204253428494739\ \(0\)\
\-\ surrounding\\:\\ 0\\.03153993290752326\ \(0\)\
\-\ vascular\\:\\ 0\\.031221032679378778\ \(0\)\
\-\ past\\:\\ 0\\.030783092004116337\ \(0\)\
\-\ while\\:\\ 0\\.030563466346835436\ \(0\)\
\-\ will\\:\\ 0\\.030437987873649215\ \(0\)\
\-\ resection\\:\\ 0\\.030314380288858973\ \(0\)\
\-\ approximately\\:\\ 0\\.030175334954660793\ \(0\)\
\-\ enhancing\\:\\ 0\\.02962521829143538\ \(0\)\
\-\ month\\:\\ 0\\.028767884049652297\ \(0\)\
\-\ his\\:\\ 0\\.028681072955759467\ \(0\)\
\-\ changes\\:\\ 0\\.0285809290529898\ \(0\)\
\-\ level\\:\\ 0\\.028566721022580274\ \(0\)\
\-\ cystic\\:\\ 0\\.028481980417165435\ \(0\)\
\-\ following\\:\\ 0\\.028370323729859263\ \(0\)\
\-\ edema\\:\\ 0\\.028205608701468574\ \(0\)\
\-\ scan\\:\\ 0\\.028057441929358273\ \(0\)\
\-\ with\\:\\ 0\\.027780721600610892\ \(0\)\
\-\ been\\:\\ 0\\.02755248499467584\ \(0\)\
\-\ significant\\:\\ 0\\.027304992475140583\ \(0\)\
\-\ t2\\:\\ 0\\.02720802781755993\ \(0\)\
\-\ low\\:\\ 0\\.027136041399583116\ \(0\)\
\-\ common\\:\\ 0\\.026819620858780906\ \(0\)\
\-\ signal\\:\\ 0\\.026808130373622247\ \(0\)\
\-\ mild\\:\\ 0\\.026808130373622247\ \(0\)\
\-\ who\\:\\ 0\\.02675091562814498\ \(0\)\
\-\ these\\:\\ 0\\.026705426440135793\ \(0\)\
\-\ over\\:\\ 0\\.026296078187259365\ \(0\)\
\-\ associated\\:\\ 0\\.02492609581924704\ \(0\)\
\-\ tumor\\:\\ 0\\.024736127815261418\ \(0\)\
\-\ other\\:\\ 0\\.02455916520069447\ \(0\)\
\-\ posterior\\:\\ 0\\.02445477284069335\ \(0\)\
\-\ it\\:\\ 0\\.024207788855660006\ \(0\)\
\-\ may\\:\\ 0\\.02379850615832897\ \(0\)\
\-\ demonstrates\\:\\ 0\\.023758667620759878\ \(0\)\
\-\ case\\:\\ 0\\.023758667620759878\ \(0\)\
\-\ large\\:\\ 0\\.023695321496213693\ \(0\)\
\-\ findings\\:\\ 0\\.023340185587875883\ \(0\)\
\-\ has\\:\\ 0\\.021601317663692225\ \(0\)\
\-\ be\\:\\ 0\\.019184216251465363\ \(0\)\
\-\ from\\:\\ 0\\.018782125307581547\ \(0\)\
\-\ an\\:\\ 0\\.01808405930393753\ \(0\)\
\-\ history\\:\\ 0\\.018068039233803148\ \(0\)\
\-\ patient\\:\\ 0\\.01538150701584189\ \(0\)\
\-\ no\\:\\ 0\\.015378613844039777\ \(0\)\
\-\ on\\:\\ 0\\.014282804030465664\ \(0\)\
